How Trust Based Is Your Joint Venture?

During a recent interview for an upcoming feature with Lara Sullivan, M.D., I asked the first-time CEO of Pyxis Oncology about building the company, doing so in “stealth mode,” and oh, by the way, executing a joint venture (JV). Here’s a video snippet of the conversation as a bit of an appetizer for the upcoming January article, “Will Pyxis Oncology Be Pfizer’s Fourth Billion-Dollar Spinout?” Don’t miss out! Subscribe now to Life science Leader.